Lakeland Bancorp Inc (LBAI) 11.49 $LBAI FDIC Approves

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lakeland Bancorp Inc (LBAI) 11.49 $LBAI

FDIC Approves Merger of Harmony Bank Into Lakeland Bank
GlobeNewswire - Thu May 19, 12:46PM CDT
Lakeland Bancorp, Inc. (NASDAQ:LBAI) (the "Company" , the parent company of Lakeland Bank, and Harmony Bank (OTCPK:HRMB) announced today that the Company has received approval from the Federal Deposit Insurance Corporation of the proposed merger of Harmony Bank with and into Lakeland Bank. The New Jersey Department of Banking and Insurance approved the merger in April 2016. The proposed merger is subject to the approval of Harmony Bank's shareholders at a special meeting of shareholders to be held on June 22, 2016, and to certain other conditions, as described in the final proxy statement and prospectus dated May 13, 2016, which has been filed with the Securities and Exchange Commission and is being mailed to Harmony Bank's shareholders.
LBAI: 11.49 (-0.06)

Lakeland Bancorp posts 1Q profit
Automated Insights - Tue Apr 26, 8:20AM CDT
OAK RIDGE, N.J. (AP) _ Lakeland Bancorp Inc. (LBAI) on Tuesday reported first-quarter net income of $8.1 million.
LBAI: 11.49 (-0.06)

Lakeland Bancorp Reports First Quarter 2016 Earnings and Increases Cash Dividend
GlobeNewswire - Tue Apr 26, 8:04AM CDT
Lakeland Bancorp, Inc. (NASDAQ:LBAI) (the "Company" reported the following results for the quarter ended March 31, 2016:
LBAI: 11.49 (-0.06)

Lakeland Bancorp Reports Record Full Year Results and Closes Pascack Bancorp Acquisition
GlobeNewswire - Thu Jan 28, 8:28AM CST
Lakeland Bancorp, Inc. (NASDAQ:LBAI) (the "Company" reported the following results for the fourth quarter of 2015 and for the year ended December 31, 2015:
LBAI: 11.49 (-0.06)

Lakeland Bancorp Third Quarter Results Driven by Strong Loan Growth; Receives Regulatory Approvals for Merger with Pascack Bancorp
GlobeNewswire - Tue Oct 27, 8:18AM CDT
Lakeland Bancorp, Inc. (NASDAQ:LBAI) (the "Company" reported the following results in the third quarter of 2015:
LBAI: 11.49 (-0.06)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Pascack Bancorp, Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to Lakeland Bancorp, Inc.
BusinessWire - Fri Aug 07, 8:28AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
LBAI: 11.49 (-0.06)

PASCACK BANCORP, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Lakeland Bancorp, Inc.
BusinessWire - Thu Aug 06, 11:51AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Pascack Bancorp, Inc. ("Pascack" (OTCMKTS: PSBR) concerning the sale to Lakeland Bancorp, Inc. Under the terms of the agreement, Pascack shareholders will receive either 0.9576 shares of Lakeland Bancorp (NasdaqGS: LBAI) stock or $11.35 in cash for each share owned.
LBAI: 11.49 (-0.06)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Pascack Bancorp, Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to Lakeland Bancorp, Inc. -- PSBR
PR Newswire - Wed Aug 05, 10:53AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
LBAI: 11.49 (-0.06)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Pascack Bancorp Concerning its Proposed Sale to Lakeland Bancorp, Inc.
BusinessWire - Tue Aug 04, 3:54PM CDT
The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Pascack Bancorp (OTC SBR) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Pascack Bancorp to maximize shareholder value before agreeing to be acquired by Lakeland Bancorp, Inc. (NASDAQ:LBAI).
LBAI: 11.49 (-0.06)

Lakeland Bancorp to Acquire Pascack Bancorp
GlobeNewswire - Tue Aug 04, 7:41AM CDT
The Boards of Directors of Lakeland Bancorp, Inc. (NASDAQ:LBAI) ("Lakeland Bancorp" , the parent company of Lakeland Bank, and Pascack Bancorp, Inc. (OTCQX SBR) ("Pascack Bancorp" , the parent company of Pascack Community Bank, announced today that the companies have entered into a definitive Agreement and Plan of Merger (the "Merger Agreement" , pursuant to which Pascack Bancorp will be merged with and into Lakeland Bancorp, with Lakeland Bancorp as the surviving bank holding company, and Pascack Community Bank will merge with and into Lakeland Bank, with Lakeland Bank as the surviving bank. The Merger Agreement provides that shareholders of Pascack Bancorp will receive, at their election, for each outstanding share of Pascack Bancorp common stock that they own at the effective time of the merger or would own upon conversion of preferred stock immediately prior to such effective time, either 0.9576 shares of Lakeland Bancorp common stock or $11.35 in cash, subject to proration as described in the Merger Agreement so that 90% of the aggregate merger consideration will be shares of Lakeland Bancorp common stock and 10% will be cash.
LBAI: 11.49 (-0.06)

Lakeland Bancorp Second Quarter Results Driven by Strong Loan Growth
GlobeNewswire - Wed Jul 22, 8:07AM CDT
Lakeland Bancorp, Inc. (NASDAQ:LBAI) (the "Company" reported the following results for the second quarter of 2015:
LBAI: 11.49 (-0.06)

BUYINS.NET: NWL, DHR, LBAI Expected To Be Up Before Next Earnings Releases
M2 - Fri Jul 03, 7:40AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and earnings reports. NEWELL RUBBERMAID INCORPORATED (NYSE:NWL), Danaher Corp (NYSE HR), Lakeland Bancorp Inc (NASDAQ:LBAI) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com . The following stocks are expected to go Up Before earnings are released Friday:
NWL: 47.95 (-1.01), LBAI: 11.49 (-0.06), DHR: 99.31 (-1.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading